New study aims to uncover hidden risks of blood transfusions in preterm babies

NCT ID NCT07672275

Recruiting now Knowledge-focused Sponsor: Medical University of Graz Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how blood transfusions affect tiny molecules called peroxides in very premature babies. These molecules can damage cells if they build up. Researchers will measure peroxide levels before and after transfusions, and also use a special light device to check oxygen in the brain. The goal is to understand these changes better and find ways to make transfusions safer for newborns.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide reference values for oxidative stress in newborns and guide safer transfusion practices for preterm infants.
What could go wrong: This is a small, early observational pilot study. It does not test a treatment, so it cannot directly improve outcomes. Results may not apply to all hospitals or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERYTHROCYTE TRANSFUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

beta thalassemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ERYTHROCYTE TRANSFUSION FETAL HEMOGLOBIN NEAR-INFRARED SPECTROSCOPY OXIDATIVE STRESS IN NEONATES

Contacts and locations

Locations

Divison of Neonatology, Department of Pediatrics, Medical University of Graz
RECRUITING

Graz, Styria, 8036, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.